Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2014
12/24/2014CN102441058B 一种养血清脑颗粒的气相色谱指纹图谱检测方法 GC fingerprint detection method Yangxueqingnao particles
12/24/2014CN102429876B 利拉鲁肽缓释微球制剂及其制备方法 Liraglutide release microsphere formulation and preparation method
12/24/2014CN102380359B 一种尺寸均一的分子印迹聚合物纳微球制备方法及应用 One size molecularly imprinted polymer microspheres Carolina uniform preparation method and application
12/24/2014CN102370817B 一种治疗头晕目眩的汤剂药物 A treatment for dizziness drug decoction
12/24/2014CN102342936B 一种氨氯地平和阿托伐他汀钙的药用组合物及其制备方法 One kind of amlodipine and atorvastatin calcium pharmaceutical composition and its preparation method
12/24/2014CN102342930B 硝酸芬替康唑药物组合物 Finland nitrate pharmaceutical compositions for itraconazole
12/24/2014CN102307568B 白藜芦醇组合物 Resveratrol composition
12/24/2014CN102028746B 一种治疗冠心病的药物及提取 Drugs and extract a treatment of coronary heart disease
12/24/2014CN102028743B 一种治疗冠心病的药物及制备 And the preparation of a drug treatment of coronary heart disease
12/24/2014CN101903017B 具有增强的脉冲活性物质释放的包衣的药物或营养制剂 Pharmaceutical or nutritional formulation having enhanced pulse release coat of the active substance
12/24/2014CN101119708B 苯达莫司汀冻干药物组合物 Bendamustine lyophilized pharmaceutical compositions
12/23/2014US8916616 Multi-functional polymeric materials and their uses
12/23/2014US8916606 Therapeutic compositions and methods for targeted delivery of active agents
12/23/2014US8916598 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
12/23/2014US8916588 Methods for treatment of attention deficit hyperactivity disorder
12/23/2014US8916583 Therapeutic compositions for intranasal administration of zolpidem
12/23/2014US8916566 Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
12/23/2014US8916562 Methods and compositions for safe and effective treatment of telangiectasia
12/23/2014US8916558 Powders for reconstitution
12/23/2014US8916546 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
12/23/2014US8916339 Spinal cord tissue dehydrated and micronized
12/23/2014US8916214 Process for preparing a free-flowing powder containing a deliquescent quaternary ammonium compound
12/23/2014US8916206 Nanoparticles containing water-soluble non-peptide low-molecular weight drug
12/23/2014US8916205 Polymeric nanoparticles for photosensitizers
12/23/2014US8916203 Stable formulations for lyophilizing therapeutic particles
12/23/2014US8916202 Floating microgranules
12/23/2014US8916201 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
12/23/2014US8916200 Nanoimprint lithography formation of functional nanoparticles using dual release layers
12/23/2014US8916199 Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
12/23/2014US8916198 Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents
12/23/2014US8916197 Bone marrow-directing drug delivery materials and their applications
12/23/2014US8916196 Method for the production of emulsion-based microparticles
12/23/2014US8916195 Sustained release formulation of naltrexone
12/23/2014US8916194 Controlled release pharmaceutical compositions of milnacipran
12/23/2014US8916193 Rifaximin complexes
12/23/2014US8916192 Method and apparatus for the preparation of capsules
12/23/2014US8916191 Device for transdermal administration of drugs including acrylic polymers
12/23/2014US8916190 Method of inducing hemostasis in a wound
12/23/2014US8916188 Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
12/23/2014US8916185 Immobilizing particles onto surfaces
12/23/2014US8916182 Composition comprising oligogalacturonans and polycationic saccharides
12/23/2014US8916171 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
12/23/2014US8916167 Treatment and diagnosis of macrophage mediated disease
12/23/2014US8916158 Formulation of human antibodies for treating TNF-α associated disorders
12/23/2014US8916157 Formulation of human antibodies for treating TNF-α associated disorders
12/23/2014US8916150 Compositions and methods for enhancing metal ion dependent drug therapies
12/23/2014US8916144 Proangiogenic compositions, method for preparing same, and uses thereof
12/23/2014US8916136 Glucose biosensor system coupled with an anti-inflammatory module and methods for using the same
12/23/2014US8916131 Radiopharmaceutical composition
12/23/2014US8915904 Implantable device with conforming telemetry coil and methods of making same
12/23/2014US8915893 Variable flow infusion pump system
12/19/2014DE202014007438U1 Flüssige Applikation von Verdauungsenzymen Cash and application of digestive enzymes
12/18/2014US20140371692 Hydrogel compositions
12/18/2014US20140371687 Device having titania nanotube membrane for drug delivery
12/18/2014US20140371662 Thermal treatment of the skin surface with metal nanoparticles in surfactant containing solutions
12/18/2014US20140371658 Thermal treatment of acne with metal nanoparticles in surfactant containing solutions
12/18/2014US20140371654 Hair removal with nanoparticles with coatings that facilitate selective removal from the skin surface
12/18/2014US20140371333 Lecithin-organogelling agent
12/18/2014US20140371317 Silicone Resin Emulsions
12/18/2014US20140371309 Ophthalmic solution
12/18/2014US20140371308 Hypotensive lipid-containing biodegradable intraocular implants and related methods
12/18/2014US20140371282 Controlled release pharmaceutical compositions with improved bioavailabililty
12/18/2014US20140371257 Pharmaceutical Formulation Containing Gelling Agent
12/18/2014US20140371197 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
12/18/2014US20140371192 Alpha-form zinc-phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an alpha-form zinc-phthalocyanine nanowire/phenothiazine, and method for preparing same
12/18/2014US20140371191 Oromucosal Liquid Estradiol Compositions
12/18/2014US20140371187 Semi-solid delivery vehicle and pharmaceutical compositions
12/18/2014US20140371151 Use of Liposomal WNT Composition to Enhance Osseointegration
12/18/2014US20140370135 Use of extracts of capraria biflora in the prevention and/or treatment of senile cataracts
12/18/2014US20140370123 Skin external composition comprising a sea salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
12/18/2014US20140370119 Arsenic Compound Solution and Albumin Nanoparticle and Lyophilized Preparation Entrapping Arsenic Compound Prepared Using Same
12/18/2014US20140370114 Homopolymer nanoparticles by self-emulsion polymerization reaction and preparation method thereof
12/18/2014US20140370113 Hydrocortisone controlled release formulation
12/18/2014US20140370112 Multiparticulate L-Carnitine Compositions and Related Methods
12/18/2014US20140370111 Protein delivery from stem cell microcarriers
12/18/2014US20140370110 Polymer conjugated protein micelles
12/18/2014US20140370109 Stabilized Granules Containing Glyceryl Trinitrate
12/18/2014US20140370107 Multilayer microincapuslated probiotic bacteria
12/18/2014US20140370106 Beadlets comprising hop acid salts in a protein matrix
12/18/2014US20140370104 Pharmaceutical formulation and method for treating acid caused gastrointestinal disorders
12/18/2014US20140370103 Non-immunogenic delivery vehicle for betta-, gamma-, and delta-tocopherols and methods of using and making same
12/18/2014US20140370102 Method and composition for pharmaceutical product
12/18/2014US20140370101 2,2',6,6'-tetraisopropyl-4,4'-biphenol lipid microsphere preparations and preparation methods therefor
12/18/2014US20140370099 Artificial antigen presenting cells having a defined and dynamic shape
12/18/2014US20140370097 Sterile pharmaceutical compositions
12/18/2014US20140370096 Gas transporting rheological medium, end uses and related apparatus-method
12/18/2014US20140370094 Silk-based scaffold platform for engineering tissue constructs
12/18/2014US20140370093 Oral antimicrobial pharmaceutical compositions
12/18/2014US20140370092 Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
12/18/2014US20140370091 Method for Producing Aqueous Enteric Coating Liquid, Solid Preparation, and Method for Producing Same
12/18/2014US20140370090 In situ, liquid-activated film coated tablets and a process for making the same
12/18/2014US20140370088 Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
12/18/2014US20140370085 Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
12/18/2014US20140370083 5-aminosalicylic acid capsule formulation
12/18/2014US20140370082 Cyclosporine analogue mixtures and their use as immunomodulating agents
12/18/2014US20140370081 Stable crystal modifications of dotap chloride
12/18/2014US20140370078 Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds
12/18/2014US20140370077 Transdermal drug delivery system containing fentanyl
12/18/2014US20140370076 Transdermal drug delivery system containing donepezil
12/18/2014US20140370069 Methods for treating an established myocardial infarction
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 2991